EDWARD KAYE plan to sell securities of CYTOKINETICS, INCORPORATED under Form 144

EDWARD KAYE filed Form 144 to notify SEC of plan to sell 2933 units of CYTOKINETICS, INCORPORATED securities around 2026-06-01, with aggregate market value of $225,137.08. The total outstanding units is 124432565.0. The amount planned to be sold represents 0.00% of total outstanding units;